Navigation Links
Volcano Announces Acquisition of Novelis, Inc.
Date:5/19/2008

Novelis' Forward-Looking IVUS technology platform expected to enable Volcano to offer an expanded line of minimally invasive diagnostic and

therapeutic devices

SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it has acquired Novelis, Inc., a privately-held company with proprietary ultrasonic visualization and therapy technology for minimally invasive diagnostic and therapeutic devices.

Novelis' proprietary Forward-Looking IVUS technology platform is expected to build upon Volcano's existing suite of products and further enhance Volcano's position as an imaging technology leader in the field of interventional medicine by enabling forward-looking IVUS and associated therapies in the interventional cardiology market. Volcano expects to add the Novelis products and capability onto its s5i multi-modality integrated platform/hub.

Novelis' core product line is based on Forward-Looking Intravascular Ultrasound (FLIVUS) technology. The product line includes an image-guided crossing catheter that combines visualization, steerability and RF tissue ablation, which is designed to permit Interventional Cardiologists to safely cross chronic total occlusions ("CTO") in the coronary and peripheral arteries, and a forward-looking IVUS catheter (imaging-only version) to facilitate current guidewire-based CTO crossing techniques as well as other potential product offerings with possible applications outside of vascular medicine. This platform tech
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
9. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
10. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
11. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: ... and commercializing innovative therapies addressing major unmet medical ... received the Notice of Allowance from the United ... self-delivering RNAi compounds (sd-rxRNA®), for the treatment of ...
(Date:1/14/2014)... UK (PRWEB) January 13, 2014 Bob ... with more than 20 years in the industry, has ... photonics . Hainsey will serve as the society’s Science ... Dr. Hainsey join SPIE as our Technology Strategist, further ...
(Date:1/14/2014)... Independent publisher Bitingduck Press, with offices in ... big ideas for 2014 in production and sales of ... produce high-quality, low-cost, DRM-free ebooks and to use the ... The first major development will be bookstore sales in ...
Breaking Biology Technology:Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... 12 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), ... the treatment of cancer and,hepatitis C virus infection ... its clinical trial designed to evaluate the safety ... patients with advanced,breast cancer. The primary objective of ...
... Calif., Feb. 12 Ardea Biosciences,Inc. (Nasdaq: RDEA ) ... Ardea Biosciences, will present at the Roth Capital Partners,20th Annual ... 19, 2008 Time: 4:00 p.m. Pacific Time ... Webcast: http://www.wsw.com/webcast/roth16/rdea/ or ...
... Also Announced, SILVER SPRING, Md., Feb. 12 ... today that it will,release its 2007 fourth quarter ... on Tuesday, February 19, 2008., United Therapeutics ... 2008, at 9:00 a.m. Eastern Time. The teleconference ...
Cached Biology Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer 4Ardea Biosciences to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference 2
(Date:4/22/2014)... This news release is available in French . ... less than a month, sequencing of the complete genome ... in Guinea forms a clade (variant) that is distinct ... Congo and in Gabon. Epidemiological investigations also linked the ... the December 2013 outbreak. , Ebola virus is a ...
(Date:4/22/2014)... projects in two Minnesota cities demonstrate how communities ... continue a ten year program in New England ... tailored to local conditions. , "Our goal is ... themselves," said program co-leader Latham Stack, of Syntectic ... already worsened. We help communities move beyond feeling ...
(Date:4/22/2014)... Most people think the development of the heart only ... birth are full of cellular changes that play a role ... models, researchers at Baylor College of Medicine have now been ... genes code proteins, determining their role) that takes place during ... The findings, which appear in Nature Communications , also ...
Breaking Biology News(10 mins):Inserm and the Institut Pasteur identify a new variant of Ebola virus in Guinea 2Minnesota projects offer hope and practical help to communities facing more extreme storms 2Protein expression gets the heart pumping 2
... pink to traditional French and Lady Gaga,s sophisticated designs, manicured ... are not just pretty when nails appeared on all ... ago, they led to the development of critical functions, including ... to grasp, whether it,s a nail polish brush or remover ...
... of produce may not be enough to remove harmful food ... Salmonella and E. coli can live inside plant ... in tissues of mung bean sprouts and Salmonella in peanut ... prior to planting. Amanda Deering, a postdoctoral researcher in food ...
... might be a time when instead of just drinking that ... as a way of preventing harmful sun damage or skin ... guards against certain skin cancers at the molecular level by ... Scientists believe that based on what they have learned studying ...
Cached Biology News:Researchers discover oldest evidence of nails in modern primates 2Researchers discover oldest evidence of nails in modern primates 3E. coli, salmonella may lurk in unwashable places in produce 2More evidence that caffeine lowers risk of skin cancer 2